PHILADELPHIA, FEBRUARY 24, 2016 — There’s a lot to consider when investigating a novel and targeted oncology compound, and decisions you make early on can have profound and lasting implications. At a webinar on Wednesday, February 24, Premier Research will show how making sound decisions from the outset can improve your odds of long-term success....
PHILADELPHIA, December 17, 2015 — Premier Research announces the appointment of Paul Hallenbeck as Executive Director for Oncology. Dr. Hallenbeck has more than 20 years of experience in the biotech industry and expertise in all phases of oncology drug discovery, development, and commercialization, including work in complex, targeted biologics. Dr. Hallenbeck most recently served as...
Premier Research Group announces the appointment of Etienne Drouet to the position of Executive Director, Oncology Europe. In this position, Mr. Drouet will play a leading role in the operations, strategic planning and corporate development of Premier Research’s growing portfolio of oncology business.